What investors make of the health tech funding dip; problems tied to inaccurate pulse oximeter readings

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Health tech funding is down. Here's what investors make of the market By Mario Aguilar Adobe Health tech funding is down, deal sizes are smaller, and M&A has slowed. Investors told STAT what they make of the market right now. Read More Inaccurate pulse oximeter readings tied to less supplemental oxygen for darker-skinned ICU patients By Usha Lee McFarling Photo by Mario Tama/Getty Images ICU patients with darker skin who received less accurate pulse oximeter readings also received less supplemental oxygen, a new study found. Read More Drugmaker seeks FDA approval of over-the-counter birth control pill By Associated Press Sarah Silbiger/Getty Images HRA Pharma's application sets up a high-stakes decision for health regulators amid battles over women's reproductive health. Read More Sponsor content by STAT Events From trials to triumph: The 2022 STAT Summit Join us as we host silo-breaking discussions on the most important topics in health care. Over two days this November, you'll hear from some of the leading minds in the industry. Don't miss out, and enjoy early-bird pricing on your pass until July 22. Opinion: Secrecy: A demon of gene therapy's past bedevils its future By Eric B. Kmiec Adobe The field of gene therapy was once severely damaged by not openly sharing essential information. It may be making the same mistake again. Read More Monday, July 11, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser